DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 15,940 Value ($000) $223 Avg Close $14.07 Range $10.57 - $16.97
Q2 2024
Shares 10,343 Value ($000) $240 Avg Close $19.20 Range $14.56 - $23.87
Q1 2024
Shares 10,369 Value ($000) $213 Avg Close $18.79 Range $15.49 - $23.52
Q4 2023
Shares 10,344 Value ($000) $222 Avg Close $19.81 Range $15.45 - $23.81
Q3 2023
Shares 10,304 Value ($000) $213 Avg Close $25.37 Range $20.52 - $30.79
Q2 2023
Shares 10,639 Value ($000) $314 Avg Close $28.12 Range $22.72 - $33.31
Q1 2023
Shares 11,339 Value ($000) $261 Avg Close $27.52 Range $21.74 - $32.81
Q4 2022
Shares 7,343 Value ($000) $204 Avg Close $29.75 Range $25.96 - $34.78
Q4 2021
Shares 9,610 Value ($000) $429 Avg Close $47.38 Range $41.10 - $56.08
Q3 2021
Shares 6,012 Value ($000) $303 Avg Close $56.36 Range $47.02 - $79.50
Q2 2021
Shares 4,983 Value ($000) $391 Avg Close $61.86 Range $49.20 - $79.70
Q4 2020
Shares 2,950 Value ($000) $247 Avg Close $60.45 Range $35.89 - $93.94
Q3 2020
Shares 9,100 Value ($000) $326 Avg Close $30.12 Range $22.36 - $39.22
Q2 2020
Shares 10,909 Value ($000) $264 Avg Close $23.51 Range $15.72 - $29.39
Q1 2019
Shares 4,229 Value ($000) $98 Avg Close $20.92 Range $17.73 - $25.05
Q4 2018
Shares 1,977 Value ($000) $41 Avg Close $18.14 Range $13.78 - $22.40